pdfjoiner

28. Parkin L, Sweetland S, Balkwill A, et al. Body mass index, surgery, and risk of
venous thromboembolism in middle-aged women: a cohort study. Circulation
2012; 125: 1897–904.
29. Demaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal
for a clinically useful score to predict mortality risk in patients undergoing gastric
bypass. Surgery for Obesity and Related Diseases 2007; 3: 134–40.
30. Magee CJ, Barry J, Javed S, Macadam R, Kerrigan D. Extended thromboprophylaxis
reduces incidence of postoperative venous thromboembolism in laparoscopic
bariatric surgery. Surgery for Obesity and Related Diseases 2010; 6:
322–5.
31. Tasali E, Ip MSM. Obstructive sleep apnea and metabolic syndrome: alterations in
glucose metabolism and inflammation. Proceedings of the American Thoracic
Society 2008; 5: 207–17.
32. Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia
in the perioperative period in noncardiac surgery. Diabetes Care 2010; 33:
1783–8.
33. Guidone C. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric
surgery. Diabetes 2006; 55: 2025–31.
34. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification
of lean body weight. Clinical Pharmacokinetics 2005; 44: 1051–65.
35. Ingrande J, Lemmens HJM. Dose adjustment of anaesthetics in the morbidly
obese. British Journal of Anaesthesia 2010; 105(Suppl. 1): i16–23.
36. Gepts E. Pharmacokinetic concepts for TCI anaesthesia. Anaesthesia 1998; 53
(Suppl. 1): 4–12.
37. Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics
of drugs in humans. Clinical Pharmacokinetics 2010; 49: 71–87.
38. Pandit JJ, Andrade J, Bogod DG, et al. The 5th National Audit Project (NAP5) on
accidental awareness during general anaesthesia: protocol, methods and analysis
of data. Anaesthesia 2014; 69: 1078–88.
39. Ingrande J, Brodsky JB, Lemmens HJM. Lean body weight scalar for the anesthetic
induction dose of propofol in morbidly obese subjects. Anesthesia and Analgesia
2011; 113: 57–62.
40. Leykin Y, Pellis T, Lucca M, Lomangino G, Marzano B, Gullo A. The pharmacodynamic
effects of rocuronium when dosed according to real body weight or ideal
body weight in morbidly obese patients. Anesthesia and Analgesia 2004; 99:
1086–9.
41. Hammoud HA, Aymard G, Lechat P, Boccheciampe N, Riou B, Aubrun F. Relationships
between plasma concentrations of morphine, morphine-3-glucuronide,
morphine-6-glucuronide, and intravenous morphine titration outcomes in the
postoperative period. Fundamental and Clinical Pharmacology 2011; 25: 518–
27.
42. Absalom AR, Mani V, De Smet T, Struys MMRF. Pharmacokinetic models for propofol-defining
and illuminating the devil in the detail. British Journal of Anaesthesia
2009; 103: 26–37.
43. Demaria EJ, Murr M, Byrne TK, et al. Validation of the Obesity Surgery Mortality Risk
score in a multicenter study proves it stratifies mortality risk in patients undergoing
gastric bypass for morbid obesity. Annals of Surgery 2007; 246: 578–84.
30 © 2015 The Authors. Anaesthesia published by John Wiley & Sons Ltd
on behalf of Association of Anaesthetists of Great Britain and Ireland